Skip to main content
Benjamin Kann, MD, Radiation Oncology, Boston, MA

Benjamin Harris Kann MD


Physician

Join to View Full Profile
  • 450 Brookline AveBoston, MA 02215

  • Phone+1 617-632-5734

  • Fax+1 617-394-2667

Dr. Kann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Radiation Oncology, 2015 - 2019
  • Mass General Brigham/Newton-Wellesley Hospital
    Mass General Brigham/Newton-Wellesley HospitalInternship, Transitional Year, 2014 - 2015
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2014

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2019 - 2026
  • CT State Medical License
    CT State Medical License 2017 - 2019
  • Clinical Informatics
    American Board of Preventive Medicine Clinical Informatics
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • Dose reduction to dysphagia/aspiration-related structures (DARS) in patients receiving induction chemotherapy (IC) followed by concurrent chemoradiation therapy (CCRT)...  
    Kann BH, Carpenter TJ, Todorov B, Cotter R, Golchin A, Bakst R, Misiukiewicz K, Posner M, Gupta V, Journal of Radiation Oncology, 9/2014

Press Mentions

  • AI Predicts Pediatric Cancer Recurrence with Impressive Accuracy
    AI Predicts Pediatric Cancer Recurrence with Impressive AccuracyApril 25th, 2025
  • AI Tool Enhances Prediction of Relapse in Pediatric Brain Cancer
    AI Tool Enhances Prediction of Relapse in Pediatric Brain CancerApril 24th, 2025
  • Artificial Intelligence Tool Helps Predict Relapse of Pediatric Brain Cancer
    Artificial Intelligence Tool Helps Predict Relapse of Pediatric Brain CancerApril 24th, 2025
  • Join now to see all

Grant Support

  • Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbidity in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI)UNIVERSITY OF TX MD ANDERSON CAN CTR2025–2030
  • Development of an artificial intelligence-driven, imaging-based platform for pretreatment identification of extranodal extension in head and neck cancerBRIGHAM AND WOMEN'S HOSPITAL2021–2025
  • Development of an artificial intelligence-driven, imaging-based platform for pretreatment identification of extranodal extension in head and neck cancerBRIGHAM AND WOMEN'S HOSPITAL2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: